Perrigo Company PLC (NYSE:PRGO) EVP Svend Andersen purchased 3,900 shares of the firm’s stock in a transaction on Friday, November 9th. The stock was acquired at an average price of $63.01 per share, for a total transaction of $245,739.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Svend Andersen also recently made the following trade(s):
- On Tuesday, August 14th, Svend Andersen purchased 7,200 shares of Perrigo stock. The stock was acquired at an average price of $69.43 per share, for a total transaction of $499,896.00.
Shares of NYSE PRGO traded up $1.19 during midday trading on Friday, reaching $64.07. The stock had a trading volume of 172,927 shares, compared to its average volume of 1,289,519. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.81 and a quick ratio of 1.23. The stock has a market cap of $10.11 billion, a PE ratio of 12.99, a price-to-earnings-growth ratio of 2.39 and a beta of 0.66. Perrigo Company PLC has a 12-month low of $62.86 and a 12-month high of $95.93.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 18th. Stockholders of record on Friday, November 30th will be paid a $0.19 dividend. The ex-dividend date is Thursday, November 29th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 1.19%. Perrigo’s dividend payout ratio (DPR) is presently 15.42%.
PRGO has been the topic of several recent research reports. Canaccord Genuity set a $90.00 price target on shares of Perrigo and gave the stock a “buy” rating in a research report on Friday, August 17th. ValuEngine downgraded shares of Perrigo from a “sell” rating to a “strong sell” rating in a research report on Friday, September 14th. Deutsche Bank downgraded shares of Perrigo from a “buy” rating to a “hold” rating and decreased their price target for the stock from $93.00 to $78.00 in a research report on Friday, August 10th. Cantor Fitzgerald reiterated a “buy” rating and issued a $107.00 price target on shares of Perrigo in a research report on Monday, October 8th. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a $73.00 price target on shares of Perrigo in a research report on Friday, August 10th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus price target of $87.80.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Piedmont Investment Advisors LLC purchased a new stake in shares of Perrigo in the second quarter worth $110,000. NuWave Investment Management LLC increased its stake in shares of Perrigo by 17,377.8% in the third quarter. NuWave Investment Management LLC now owns 1,573 shares of the company’s stock worth $111,000 after purchasing an additional 1,564 shares in the last quarter. Dupont Capital Management Corp increased its stake in shares of Perrigo by 63.8% in the second quarter. Dupont Capital Management Corp now owns 1,705 shares of the company’s stock worth $124,000 after purchasing an additional 664 shares in the last quarter. Allianz Asset Management GmbH purchased a new stake in shares of Perrigo in the first quarter worth $205,000. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Perrigo during the first quarter valued at $208,000. 83.00% of the stock is owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: This story was first published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://sportsperspectives.com/2018/11/09/svend-andersen-buys-3900-shares-of-perrigo-company-plc-prgo-stock.html.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
Recommended Story: What is a Swap?
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.